| "Lysophosphatatidic Acid Contributes to the Development and Outcome of Breat and Ovarian Cancer: A New Validated Target"
Gordon Mills, MD, PhD
Chairman, Department of Molecular Therapeutics
Professor of Medicine
M.D. Anderson Cancer Center, University of Texas
When: 12:00 p.m.
Where: DFCI Smith 960/964
|